| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.81▲ | 0.81▲ | 0.81▲ | 0.77▲ | 0.75▲ |
| MA10 | 0.81▲ | 0.80▲ | 0.81▲ | 0.73▲ | 0.81▼ |
| MA20 | 0.81▲ | 0.81▲ | 0.79▲ | 0.76▲ | 0.95▼ |
| MA50 | 0.81▼ | 0.77▲ | 0.74▲ | 0.87▼ | 1.13▼ |
| MA100 | 0.79▲ | 0.74▲ | 0.73▲ | 0.98▼ | 1.22▼ |
| MA200 | 0.75▲ | 0.75▲ | 0.76▲ | 1.10▼ | 3.20▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.002▼ | -0.002▼ | 0.018▲ | -0.015▼ |
| RSI | 52.377▲ | 56.195▲ | 61.870▲ | 53.254▲ | 43.183▼ |
| STOCH | 34.209 | 62.680 | 47.299 | 60.706 | 29.716 |
| WILL %R | -22.066▲ | -43.805 | -29.421 | -16.774▲ | -67.242 |
| CCI | 30.255 | 1.264 | 20.893 | 168.992▲ | -50.112 |
|
Wednesday, July 02, 2025 05:00 PM
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...
|
|
Monday, June 23, 2025 06:15 AM
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll ...
|
|
Thursday, June 12, 2025 05:00 PM
Duane Nash, the Executive Chairman of $IMUX, bought 20,000 shares of the company on 06-13-2025 for an estimated $16,694. This trade was reported by Quiver ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/07/25 | 0.83 | 0.83 | 0.78 | 0.806 | 663,600 |
| 08/07/25 | 0.78 | 0.832 | 0.762 | 0.829 | 1,130,100 |
| 07/07/25 | 0.74 | 0.777 | 0.734 | 0.765 | 1,302,176 |
| 03/07/25 | 0.70 | 0.746 | 0.70 | 0.7272 | 605,000 |
| 02/07/25 | 0.7034 | 0.72 | 0.6921 | 0.713 | 776,136 |
| 01/07/25 | 0.72 | 0.74 | 0.69 | 0.69 | 962,500 |
| 30/06/25 | 0.71 | 0.727 | 0.69 | 0.6975 | 1,550,465 |
| 27/06/25 | 0.715 | 0.72 | 0.69 | 0.70 | 753,800 |
| 26/06/25 | 0.70 | 0.75 | 0.683 | 0.71 | 1,286,300 |
| 25/06/25 | 0.72 | 0.739 | 0.696 | 0.701 | 1,247,000 |
|
|
||||
|
|
||||
|
|